Skip to main content
. 2016 Jul 7;12(7):e1005748. doi: 10.1371/journal.ppat.1005748

Table 4. siRNAs used in this study.

# Name Sequence (5‘→3‘) 1 Company (catalog no.) Use
143 siSTAT3_1 UCUAGGUCAAUCUUGAGGCdCdT Ambion (s743) STAT3 knock-down
151 siSTAT3_2 AAUCUUAGCAGGAAGGUG CdCdT Ambion (s745) STAT3 knock-down
165 siJAK1_1 UUGUCAUCAACGGUGAUGGdTdG Ambion (s7646) JAK1 knock-down
166 siJAK1_2 UCCAUGAUGAGCUUAAUACdCdA Ambion (s7647) JAK1 knock-down
169 siIFNGR1_1 UACGAGUUUAAAGCGAUGCdTdG Ambion (s7193) IFNGR1 knock-down
170 siIFNGR1_2 UCAAUUGUAACAUUAGUUGdGdT Ambion (s7194) IFNGR1 knock-down
173 siIL6ST_1 UAAGAUACUAGACAGUUCCd TdC Ambion (s7317) IL6ST knock-down
174 siIL6ST_2 UAAUCAACAGUGCAUGAGGdTdG Ambion (s7318) IL6ST knock-down
149 siControl 2 unknown 21-mer Ambion (4390843) non-targeting control

1 guide (antisense) strand; d, desoxy.

2 Silencer Select Negative Control No. 1 siRNA.